Home›People›Holly Magliochetti
HM

Holly Magliochetti

CEO and Co-Founder, director at Pangia Biotech.

ExecutiveDirector
Updated Nov 10, 2026·Latest SEC filing May 11, 2026·Suggest an edit

About Holly Magliochetti

Holly Magliochetti is CEO and Co-Founder, director at Pangia Biotech.

Experience

This experience comes from Holly Magliochetti's profile and from SEC filings. For roles taken from filings, the years are when the filings name Holly Magliochetti in the role, so the role may have started earlier or lasted longer.

Pangia Biotech, Inc. Current
Chief Executive Officer and Co-Founder (2023 – Present)
Director
2023 – Present · Delray Beach, FL
Develops urine-based cancer tests for clinicians and patients.
Genetics Institute of America Current
Founder and Chairman of the Board
2017 – Present
Grace Health Technology
Founder and Chairman of the Board
2017 – 2026
Sympta Corporation
President
2016 – 2017
Archer Capital
Managing Partner
2006 – 2017
IPC Sports Corp.
CEO
2012 – 2015
IPC Medical Corp.
President
2010 – 2014
American Diversified Medical Corp.
President
2009 – 2010
Atmosphere
President
2009 – 2010
Yatinoo, Inc.
Vice President
2008 – 2009

Key Colleagues at Startups

The people Holly Magliochetti works with at each company, as listed on that company's latest Form D.

Pangia Biotech, Inc. · Form D, May 11, 2026
OP
Obdulio Piloto
Chief Scientific Officer and Co-Founder
GR
Garth Lees-Rolfe
Audit Committee Chair
Caroline Popper
Caroline Popper
Strategic Advisor, Commercialization & Market Access

Sources

  1. SECPangia Biotech, Inc. Form D, filed May 11, 2026